Can a smartphone app help gastric cancer patients recover faster after surgery?

NCT ID NCT07441850

First seen Jun 24, 2026 · Last updated Jun 24, 2026

Summary

This trial tests whether a smartphone-based program combining exercise, nutrition advice, and psychological support can reduce complications and improve recovery in 186 gastric cancer patients undergoing neoadjuvant therapy and surgery. Participants follow the program from before surgery until four weeks after discharge. The study compares this approach to standard care and also checks if the smartphone platform improves patient adherence compared to phone calls.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GASTRIC CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Beijing Friendship Hospital, Capital Medical University

    RECRUITING

    Beijing, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

perioperative multimodal rehabilitation program (exercise, nutrition, and psychological support) delivered via smartphone platform

What this could lead to

If successful, this could provide a practical, low-cost way to improve recovery and reduce complications after gastric cancer surgery.

What could go wrong

This is a relatively small, early-stage study testing a behavioral intervention, so results may not be generalizable. Adherence to the program could be low, and the smartphone platform may not work for all patients.

Conditions

The condition(s) this trial relates to.

gastric neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.